Isa TanTec Launches Its TrimTec Production Line in Saigon Tantec, Becoming One of the First Leather Label Manufacturers in Vietnam
ISA TanTec , an eco-friendly leather manufacturer known for the LITE (Low Impact To the Environment) Trademark, has announced the launch of its TrimTec production line, which specializes in jeans labels, trims for apparel, bags and shoes, in Saigon TanTec in September.
ISA has 3 ultra-modern tanneries located in the USA, Vietnam and China and currently has its TrimTec production based in China. Having an increasing number of customers located in Vietnam, a more advanced TrimTec production line will be launched in Saigon TanTec to support the local demand.
According to Carl Flach, Senior Director Operational Strategies of ISA TanTec, “The company is in close proximity to the customers. We are also investing in new machineries to accommodate the customers’ need for speed to market and flexibility.”
“Our aim is to be the trusted local supplier. We can now react faster to the demand, while the same level of quality, LITE and RSL standard are guaranteed,” he added.
Having production in several locations enables TrimTec to support sales at all levels – the company is working with all type of companies, ranging from international brands, trading companies to direct garment manufacturers.
Given that Vietnam is developing a series of new partnerships, which include numerous free trade agreements with different countries, ISA is able to accelerate its further growth ambitions and consolidate its global presence in one of the most dynamic regions in the world.
ISA TanTec Limited
Tel. no (China): +86-138-2802-9335
Tel. no (Macau): +853-6263-0008
Fax no.: +853-2835-6319
General Manager ISA TrimTec
Mob. no.: +86-138-2239-9971
Tel. no.: +853-2835-6320
Fax no.: +853-2835-6319
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
MA-TAKEDA/SEATTLE10.12.2017 14:02 | pressemeddelelse
Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
ASTRAZENECA9.12.2017 19:02 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial
JANSSEN9.12.2017 18:21 | pressemeddelelse
Sustained Benefit in Patients with Relapsed/Refractory Mantle Cell Lymphoma Demonstrated by 3.5 Year Follow-up Data of Imbruvica®▼(ibrutinib)
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum